Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/22/2012. Reported reason: Other

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-492-27
Dosage Form
Injection
Presentation
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)
Initial Posting
02/22/2012
Revised Date

Reason

Other